CTT Pharmaceutical Holdings Inc. (NASDAQ: CTTH) Chief Executive Officer Ryan Khouri purchased 2,100 ordinary shares on August 24, 2026, for a total of $115 at $0.055 per share, according to a U.S. Securities and Exchange Commission filing.
The transaction increased Khouri’s direct ownership to 9,360,756 ordinary shares. The company’s market capitalization stands at approximately $3.35 million, classifying it as a micro-cap issuer. CTTH shares were trading near $0.06 at the time of the filing.
InvestingPro data indicates the stock is trading above fair value and ranks among the most overvalued shares in its universe. The company’s financial health is rated as “FAIR,” and it has yet to report profitability over the past 12 months. Despite this, the stock has delivered a 63% return over the last year, according to the data provider.
